Mitora™ is a leading global supplier of high-purity senolytic compounds, dedicated to supporting cutting-edge research in aging, oncology, and cellular biology. Our product portfolio includes Dasatinib, Quercetin, Fisetin, Piperlongumine, UBX1325, Navitoclax (ABT-263), HSP90 inhibitors (17-DMAG), and Ouabain, as well as D+Q (Dasatinib + Quercetin) senolytic combinations, all available in bulk for laboratories, academic institutions, and B2B distributors worldwide.
At Mitora™, we prioritize quality, consistency, and compliance, sourcing our compounds from trusted facilities and ensuring research-grade standards for every product. Our goal is to provide reliable, high-purity senolytic solutions that accelerate scientific discovery while offering flexible B2B supply options for bulk procurement.
Whether you are a research laboratory, distributor, or pharmaceutical partner, Mitora™ is your trusted senolytic supplier, delivering premium compounds with global reach, professional support, and a commitment to advancing scientific innovation.
Copyright©2023 Mitora™
Powered by Mitora™